Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Huachuang Securities: This year, the capital for fiscal projects is relatively abundant, with less resistance to the start of construction for infrastructure projects than last year.

Oil Holds Elevated Levels as Supply Shock Risks Extend Into 2027

Alibaba and Tencent Lose $66 Billion as AI Hype Meets Reality
Huachuang Securities: This year, the capital for fiscal projects is relatively abundant, with less resistance to the start of construction for infrastructure projects than last year.

Oil Holds Elevated Levels as Supply Shock Risks Extend Into 2027

Alibaba and Tencent Lose $66 Billion as AI Hype Meets Reality

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


